Combined Effects Of Autogenic Drainage and Segmental Breathing Techniques in Chronic Obstructive Pulmonary Disease
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Enrollment
- 40
- Locations
- 2
- Primary Endpoint
- SPIROMETER
Study Overview
Brief Summary
Chronic obstructive pulmonary disease is one of the most common life threatening disease affecting population. It is a preventable and treatable lung disease. People with COPD must work harder to breathe, which can lead to shortness of breath and/or feeling tired. Autogenic drainage (AD) works by adapting your breathing and maximizing airflow within the airways to improve ventilation and clear sputum. Segmental breathing, also referred to as localized expansion breathing, is the exercise used to improve ventilation and oxygenation. This research of randomized controlled trial will check the combined effects of segmental breathing technique and autogenic drainage technique in chronic obstructive pulmonary disease by taking sample of 40 patients through non probability convenient sampling and randomly allocating them into two groups A and B out of which A will receive both autogenic drainage and segmental breathing technique, B will receive autogenic drainage only for upto the duration of 3 days per week(20-45 min) for upto 4 weeks.Pre and post training outcomes will be measured through pulse oximeter,spirometer and BCSS.The data will be analyzed through SPSS 25.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Single (Participant)
Eligibility Criteria
- Ages
- 40 Years to 60 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Age between 40 - 60 years.
- •Diagnosed moderate COPD patients according to GOLD criteria.
- •FEV / FVC ratio < 70 years
- •Stable patients can understand written and oral english,urdu trial information.
Exclusion Criteria
- •Pregnancy, due to the Pressure on pelvic and Abdomen muscles.
- •Malignant disease
- •Severe (RA)
- •Diagnosis of Asthma and major diseases, functionally limiting diseases, life expectancy < 3 months.
- •Neurological disorders
Outcomes
Primary Outcomes
SPIROMETER
Time Frame: baseline and fourth week
The most used pulmonary function test is spirometry. It assesses the capacity of the lungs to breathe in and out, especially the volume and/or velocity of air that can be expelled. When evaluating breathing patterns to detect diseases including asthma, pulmonary fibrosis, cystic fibrosis, and COPD, spirometry is useful. An FEV1/FVC ratio larger than 0.70 with both FEV1 and FVC over 80% of the expected value are considered normal spirometry data. TLC exceeding 80% of the predicted value is typical in the event that lung volumes are measured. Diffusion capacity that is more than 75% of the expected value is likewise regarded as typical
BREATHLESSNESS COUGH SPUTUM SCALE(BCSS)
Time Frame: baseline and fourth week
The breathlessness cough sputum scale tool is an effective means for measuring the impact of Pulmonary rehabilitation on improving patient tolerance and self reported symptoms as the result of COPD
PULSE OXIMETER
Time Frame: baseline and fourth week
Pulse oximetry operates by shining a light through the skin at two different wavelengths\_660 nm(red) and 940nm(infrared)\_ and measuring the difference in light absorbance at the two wavelengths to estimate an arterial oxygen saturation
Secondary Outcomes
No secondary outcomes reported